Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LFNG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KAZN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM222A-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ITFG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100129726 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IQCH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACTG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP9X - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNRC6B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRIQ1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIAH3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC5A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SERPINI2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RSPH9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGF2BP2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CFAP206 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMD7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on